Lanfear Capital Advisors
Lanfear Capital is a venture capital firm based in Palo Alto, California, that focuses on seed and early-stage investments primarily within the therapeutic, device, and biopharma sectors. The firm seeks investment opportunities where it can contribute beyond just financial support, actively engaging with entrepreneurs and management teams to address challenges and enhance value creation. With decades of experience and extensive industry relationships, Lanfear Capital aims to foster dynamic partnerships that align interests in building sustainable growth. The firm's operating philosophy emphasizes capability, integrity, and professionalism, and it also invests in select venture funds that share its approach.
https://crunchbase.com/organization/***
1 past transactions
InteKrin
Debt Financing in 2006
InteKrin Therapeutics is a clinical-stage, privately held biopharmaceutical company dedicated to developing and commercializing innovative therapeutics for neuroendocrine, metabolic, and immune disorders. The company is focused on addressing critical healthcare challenges, particularly in diseases such as diabetes, metabolic syndrome, and cancer, which require new treatment options to improve patient outcomes and reduce healthcare costs. InteKrin is actively in-licensing both early- and late-stage compounds aimed at exploring the intricate hormonal relationships influencing metabolism, insulin resistance, and obesity. Among its key developments is INT131, a non-TZD peroxisome proliferator-activated receptor gamma modulator designed to treat Relapsing Remitting Multiple Sclerosis, which seeks to provide neuroprotection while halting the progression of this serious condition.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.